1[1]Lynch JJ, Baskin EP, Nutt EM, et al. Comparison of binding to rapidly activating delayed rectifyier K+ channel, Ikr and effects on myocardial refractoriness for class Ⅲ antiarrhythmic agents [ J ]. J Cardiovase Pharmacol, 1995, 25 (2): 336-340
2[2]Demolis JL, Funck - brentano C, Ropers J, et al. Influence of dofetilide on QT - interval duration and dispersion at various heart rates during exercise in humans[J]. Circulation, 1996, 94 (7): 1592-1599
3[3]Marschang H, Beyer T, Karolyi L, et al. Differential rate and potassium- dependent effects of the class Ⅲ agents d - sotalol and dofetilide on guinea pig papillary muscle [J]. Cardiovasr Drugs Ther, 1998, 12(6) :573-583
4[4]Rousseau MF, Massart PE, De kock M, et al. Cardiac function and QT disperision during Ⅳ antiarrhythmic dosingin heart fail ure patients: superiority of dofetilide over amiodarone[J]. Circu lation, 1996, 94 (8 Suppl 1 ): 245
5[5]Decara JM, Pollak A, Dubrey, et al. Positive atrial inotropic ef fects of dofetilide following cardioversion of atrial fibrillation(ab stract) [J ]. Am J Cardiol, 2000, 86(6) :685-688
6[6]Allen MJ, Nichols DJ, Oliver SD. The pharmacokinetics and pha rmacodynamics of oral dofetilide after twice daily and three times daily dosing. Br J Clin Pharmacol, 2000, 50(3): 247-253
7[7]Kalus JS, Mauro VF. Dofetilide:a class Ⅲ - specific antiarrhyth mic agent[J ]. Ann Pharmacother, 2000, 34( 1 ) :44-46
8[8]Singh S, Zoble RG, Yellen L, et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinusrhytnm in pa tients with chronic atrial fibrillation or atrial flutter: the symp tomatic atrial fibrillation investiagativr research on dofetilide (SAFIRE - D) study [ J ]. Circulation, 2000, 102 ( 19 ): 2385- 2390
9[9]Grenbaum RA, Campbell TJ, Channer KS, et al. Conversion of a trial fibrillation and maintenance of sinus rhythm by dofetilide. The EMERALD(European and Australian Multicenter Evalua tive Research on Atrial Fibrillation Dofetilide) Study (abstract) [J]. Circulation, 1998(Suppl I) :633
10[10]Pedersen OD, Bagger H, Keller N, et al. Efficacy of dofetilide in the treatment of atrial fibrillation- flutter in patients with re duced left ventricular function: a Danish investigations of ar rhythmia and mortality on dofetilide (diamond) substudy [ J ]. Circulation, 2001,104(3) :292-296
